Drugs / NYVAC-HIV-PT1
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01783977 | Apr 2013 → Sep 2014 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT01799954 | Aug 2012 → Dec 2014 | HIV infectious disease | HIV Vaccine Trials Network | Completed | No outcome recorded |
| Phase 1 | NCT01927835 | ? → Jan 2017 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded |
| Phase 1 | NCT01964937 | ? → Apr 2014 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NYVAC-HIV-PT1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01799954 ↗ |
| Modality | Vaccine | “NYVAC HIV vaccine” NCT01783977 ↗ |
| Route | Intramuscular | “administered as 1 mL IM in participant's deltoid” NCT01783977 ↗ |